TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33017434

Group type: EXPERIMENTAL
Intervention: 100% enteral nutrition (EN)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 50% enteral nutrition (EN)
Number of subjects: 6
Study: 35387577

Group type: EXPERIMENTAL
Intervention: NIATx strategy (Cohort 1, n=25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist control (Cohort 2, n=24)
Number of subjects: 49
Study: 34511513

Group type: EXPERIMENTAL
Intervention: HiBalance program (cognitively demanding balance and gait training)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Active control speech training program
Number of subjects: 95
Study: 32077207

Group type: EXPERIMENTAL
Intervention: Temelimab 6 mg/kg
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 35149854

Group type: EXPERIMENTAL
Intervention: IXA + BEV
Number of subjects: 76

Group type: COMPARATOR
Intervention: IXA
Number of subjects: 76
Study: 33626033

Group type: EXPERIMENTAL
Intervention: Shoulder elevation group using the inhibition method (the unaffected hand assists the affected shoulder to elevate above 90°)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Back group (the unaffected hand assists the affected upper limb in the low back and keeps it in an extended position)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no upper limb intervention)
Number of subjects: 60
Study: 35351406

Group type: EXPERIMENTAL
Intervention: Video education about the Genetic Information Nondiscrimination Act
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (infographic about cell-free DNA only)
Number of subjects: 160
Study: 33006003

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Therapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Short‐Term Psychoanalytic Psychotherapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Brief Psychosocial Intervention
Number of subjects: 102
Study: 35687900

Group type: EXPERIMENTAL
Intervention: NavSTAR patient navigation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 0
Study: 33235040

Group type: EXPERIMENTAL
Intervention: Percutaneous pinning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External fixation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Volar locking plates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Casting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Volar locking plate
Number of subjects: 0
Study: 34003568

Group type: EXPERIMENTAL
Intervention: Triple therapy regimen (hydrocortisone 50 mg/6-h IV for 7 days, vitamin C 1.5 g/6-h IV for 4 days, thiamine 200 mg/12-h IV for 4 days)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Hydrocortisone monotherapy (hydrocortisone 50 mg/6-h IV for 7 days)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Triple therapy regimen
Number of subjects: 94

Group type: COMPARATOR
Intervention: Hydrocortisone monotherapy
Number of subjects: 94
Study: 34791973

Group type: EXPERIMENTAL
Intervention: Aerobic training combined with clinical Pilates exercises (CPE)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Aerobic training alone
Number of subjects: 28
Study: 33534617

Group type: EXPERIMENTAL
Intervention: Sitafloxacin 100 mg qd
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Sitafloxacin 100 mg bid
Number of subjects: 343

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg qd
Number of subjects: 343
Study: 35339694

Group type: EXPERIMENTAL
Intervention: Magnesium-based infiltrate
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Lidocaine infiltrate
Number of subjects: 44

Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 44
Study: 34391281

Group type: EXPERIMENTAL
Intervention: Intramuscular stimulation (IMS) to the pronator teres muscle, depth of 45-50 mm, 7 treatments over 7 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group received acupuncture needle at Li11, depth of 4-5 mm, 7 treatments over 7 weeks
Number of subjects: 75
Study: 32223567

Group type: EXPERIMENTAL
Intervention: PCI with sirolimus-eluting stents
Number of subjects: 600

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 600
Study: 35964335

Group type: EXPERIMENTAL
Intervention: W1 (orthotic wedges with foot assessment technique 1)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: W2 (orthotic wedges from a new assessment technique)
Number of subjects: 35

Group type: COMPARATOR
Intervention: W1
Number of subjects: 35

Group type: COMPARATOR
Intervention: Shod (control condition)
Number of subjects: 35
Study: 34520881

Group type: EXPERIMENTAL
Intervention: One application of 6% hydrogen peroxide with nitrogen TiO2 nanoparticles for 72 minutes
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Two applications of 6% hydrogen peroxide with nitrogen TiO2 nanoparticles for 36 minutes each
Number of subjects: 27
Study: 35318791

Group type: EXPERIMENTAL
Intervention: Mixed preparation containing piperine, capsaicin, and curcumin, applied topically twice daily for 3 months.
Number of subjects: 60

Group type: COMPARATOR
Intervention: 5% minoxidil, applied topically once daily for 3 months.
Number of subjects: 60
Study: 34806608

Group type: EXPERIMENTAL
Intervention: Caregiver-focused group (Cg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Patient-focused group (Pg)
Number of subjects: 50
Study: 34785697

Group type: COMPARATOR
Intervention: 20% O2 (group A)
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: 5% O2 (group B)
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: 5% O2 until Day 6 (group B')
Number of subjects: 773

Group type: EXPERIMENTAL
Intervention: Switch to 20% O2 from Day 2 to Day 6 (group C)
Number of subjects: 773
Study: 32059078

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L crosswalk
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5L value set
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incremental QALYs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Probability of cost-effectiveness
Number of subjects: 0
Study: 35975663

Group type: EXPERIMENTAL
Intervention: Real RS‐tDCS
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham RS‐tDCS
Number of subjects: 26
Study: 32542733

Group type: EXPERIMENTAL
Intervention: Tigilanol tiglate (TT) 1 mg/mL injected intratumorally
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Tigilanol tiglate (TT) after retreatment
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 123
Study: 32762030

Group type: EXPERIMENTAL
Intervention: Silybum marianum extract (400 mg/d)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32816564

Group type: EXPERIMENTAL
Intervention: AIM HI training condition
Number of subjects: 189

Group type: COMPARATOR
Intervention: Usual Care condition
Number of subjects: 189
Study: 32298428

Group type: EXPERIMENTAL
Intervention: Implementation of adapted WHO PEN guidelines and structured training for health workers
Number of subjects: 1174

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1174
Study: 33221096

Group type: EXPERIMENTAL
Intervention: Bonded spurs combined with posterior build-ups
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional bonded spurs
Number of subjects: 49
Study: 33045501

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (50 mg orally every 8 hours during labor)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate
Number of subjects: 300
Study: 35752091

Group type: EXPERIMENTAL
Intervention: 36 mg/ml e‐cigarette
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: 8 mg/ml e‐cigarette
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: 0 mg/ml e‐cigarette
Number of subjects: 520

Group type: COMPARATOR
Intervention: Cigarette-substitute (CS)
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Total nicotine exposure
Number of subjects: 520
Study: 33383635

Group type: EXPERIMENTAL
Intervention: Inadequate fruit and vegetable intakes
Number of subjects: 27497

Group type: EXPERIMENTAL
Intervention: Consumed carbonated soft drinks at least once a day
Number of subjects: 27497

Group type: EXPERIMENTAL
Intervention: Consumed fast food at least three days/week
Number of subjects: 27497

Group type: EXPERIMENTAL
Intervention: Sedentary behavior
Number of subjects: 27497

Group type: EXPERIMENTAL
Intervention: Current E-cigarette users
Number of subjects: 27497

Group type: EXPERIMENTAL
Intervention: Ever/current alcohol drinkers
Number of subjects: 27497

Group type: EXPERIMENTAL
Intervention: Adolescents from urban schools
Number of subjects: 27497

Group type: EXPERIMENTAL
Intervention: Adolescents of higher school grade
Number of subjects: 27497

Group type: EXPERIMENTAL
Intervention: Adolescents whose parents are married but living apart
Number of subjects: 27497
Study: 32738662

Group type: EXPERIMENTAL
Intervention: iApp group (immediate-use group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: dApp group (delayed-use group)
Number of subjects: 50
Study: 36228453

Group type: EXPERIMENTAL
Intervention: ISP group received bilateral ultrasound guided ISP block at the level of C5 using 20 ml bupivacaine 0.25% on each side
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ISP group
Number of subjects: 60
Study: 35698124

Group type: EXPERIMENTAL
Intervention: Group acupuncture (AP)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Individual acupuncture (AP)
Number of subjects: 11
Study: 33729664

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 32573166

Group type: EXPERIMENTAL
Intervention: Femoral plasty enhancement (Group A)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Femoral plasty enhancement (Group B)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (corresponding contralateral specimens)
Number of subjects: 18
Study: 34427849

Group type: EXPERIMENTAL
Intervention: Spiritual care based on the Sound Heart Model; 8 individual counseling sessions, 15-45 minutes each, face-to-face during dialysis, once a week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 32901441

Group type: EXPERIMENTAL
Intervention: New template
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard template
Number of subjects: 36
Study: 34490822

Group type: EXPERIMENTAL
Intervention: 11+ Injury Prevention Program (IPP)
Number of subjects: 100
Study: 33208826

Group type: EXPERIMENTAL
Intervention: Obesity (BMI ≥ 30 kg/m2)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Class III obesity
Number of subjects: 87
Study: 34910161

Group type: EXPERIMENTAL
Intervention: HIIT with FOS-enriched inulin (12 g·d‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: HIIT with maltodextrin/placebo
Number of subjects: 40
Study: 34547069

Group type: EXPERIMENTAL
Intervention: Air polishing with erythritol powder before ultrasonic scaling (Group A)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Air polishing with erythritol powder after ultrasonic scaling (Group B)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Comparison of Group A and Group B
Number of subjects: 10
Study: 33784438

Group type: EXPERIMENTAL
Intervention: Antenatal nutritional supplements
Number of subjects: 467
Study: 32609230

Group type: EXPERIMENTAL
Intervention: MI Paste (MP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fluoride dentifrice (FD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MI Paste Plus (MPP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Silica dentifrice without fluoride (CO)
Number of subjects: 10
Study: 34371872

Group type: EXPERIMENTAL
Intervention: Peptide formula (PF) 1.5 kcal/mL
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard intact protein formula (SF)
Number of subjects: 26
Study: 33162512

Group type: EXPERIMENTAL
Intervention: ATRA + ATO
Number of subjects: 0

Group type: COMPARATOR
Intervention: ATRA + chemotherapy
Number of subjects: 0
Study: 34403141

Group type: EXPERIMENTAL
Intervention: 5 mg of intravenous squalene twice a day and standard treatment for 6 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 30
Study: 33949762

Group type: EXPERIMENTAL
Intervention: Mother Matters (intervention)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 98
Study: 35488787

Group type: EXPERIMENTAL
Intervention: Esketamine (0.3 mg/kg) combined with propofol
Number of subjects: 102

Group type: COMPARATOR
Intervention: Dezocine (0.05 mg/kg) combined with propofol
Number of subjects: 102
Study: 32997817

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) associated with Preventive Oral Care Program (POCP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (POCP only)
Number of subjects: 48
Study: 33739022

Group type: EXPERIMENTAL
Intervention: Nolasiban 900 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nolasiban 1800 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nolasiban (both dosages)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Meal consumption (control for QTc assessment)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sex hormones (independent assessment)
Number of subjects: 45
Study: 34460345

Group type: EXPERIMENTAL
Intervention: Caregiver strain measurement using validated tools
Number of subjects: 851

Group type: EXPERIMENTAL
Intervention: Factors associated with caregiver strain
Number of subjects: 851
Study: 32020824

Group type: EXPERIMENTAL
Intervention: Combination treatment (0.04% tretinoin microspheres + 1% clindamycin)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Monotherapy (0.025% tretinoin)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Monotherapy (1% clindamycin)
Number of subjects: 750
Study: 35041627

Group type: COMPARATOR
Intervention: Clear fluids only (prep 1)
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Standard regimen plus 500 mL PEG after SBCE ingestion (prep 2)
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Standard regimen plus 2 L PEG plus 500 mL PEG after SBCE ingestion (prep 3)
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Prep 2 and 3 groups
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: Prep 2 group
Number of subjects: 834
Study: 34377527

Group type: EXPERIMENTAL
Intervention: Swank diet
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Wahls diet
Number of subjects: 87
Study: 33373286

Group type: EXPERIMENTAL
Intervention: Spray-inoculated with a suspension of conidia (1×10^5 spores/ml) for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 18
Study: 35615776

Group type: EXPERIMENTAL
Intervention: Behavioural interventions (including text messages)
Number of subjects: 13
Study: 32204957

Group type: EXPERIMENTAL
Intervention: Higher years of schooling
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Higher urate levels
Number of subjects: 45
Study: 36152778

Group type: EXPERIMENTAL
Intervention: Intravenous alcohol (target level: 0.05 g%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35645071

Group type: EXPERIMENTAL
Intervention: Diode laser (970 ± 15 nm)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline irrigation
Number of subjects: 45
Study: 36219172

Group type: EXPERIMENTAL
Intervention: 9-minute withdrawal time (9MF)
Number of subjects: 733
Study: 33383230

Group type: EXPERIMENTAL
Intervention: Mind (tablet‐based cognitive training)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Move (lifestyle physical activity with goal‐setting and group meetings)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: MindMoves (combined intervention of Mind and Move)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: MindMoves
Number of subjects: 254
Study: 35389906

Group type: EXPERIMENTAL
Intervention: Core decompression (CD) with bone marrow aspiration concentrate (BMAC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Core decompression (CD) alone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Core decompression (CD) with polymethylmethacrylate cement (PMMA)
Number of subjects: 40
Study: 34348526

Group type: EXPERIMENTAL
Intervention: Drospirenone 4 mg
Number of subjects: 1190

Group type: COMPARATOR
Intervention: Desogestrel 75 µg
Number of subjects: 1190
Study: 32416442

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle exercise (IME) at 60% maximal inspiratory pressure (PImax)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle exercise (IME) at 2% maximal inspiratory pressure (PImax)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Inspiratory muscle exercise (IME) at 60% PImax
Number of subjects: 14
Study: 34989404

Group type: EXPERIMENTAL
Intervention: Amaka-parents intervention
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Amaka-community intervention
Number of subjects: 636

Group type: COMPARATOR
Intervention: Control condition (usual care)
Number of subjects: 636
Study: 33137403

Group type: EXPERIMENTAL
Intervention: Duck circovirus (DuCV) infection
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: DuCV strains AHAU9, AHAU25, AHAU28, AHAU37, and AHAUHQ
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Recombination analysis of DuCV-1d subtype strains
Number of subjects: 69
Study: 32664877

Group type: EXPERIMENTAL
Intervention: Cinepazide maleate injection (320 mg, intravenous infusion, once daily for 14 days)
Number of subjects: 937

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 937
Study: 35490210

Group type: EXPERIMENTAL
Intervention: Visser reference curve
Number of subjects: 12953

Group type: EXPERIMENTAL
Intervention: Hoftiezer chart
Number of subjects: 12953

Group type: EXPERIMENTAL
Intervention: INTERGROWTH chart
Number of subjects: 12953

Group type: COMPARATOR
Intervention: All three charts
Number of subjects: 12953
Study: 32442258

Group type: EXPERIMENTAL
Intervention: SAVR
Number of subjects: 223

Group type: COMPARATOR
Intervention: TAVR
Number of subjects: 223
Study: 33468249

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate (GS; 1500 mg) and bovine chondroitin sulfate (CS; 1200 mg)
Number of subjects: 627

Group type: COMPARATOR
Intervention: Reference product (RP)
Number of subjects: 627
Study: 35842711

Group type: EXPERIMENTAL
Intervention: Cardiac patients (n = 139)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: CABG group
Number of subjects: 139
Study: 36281090

Group type: EXPERIMENTAL
Intervention: Telephone follow-up by clinical pharmacists
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 120
Study: 33026719

Group type: EXPERIMENTAL
Intervention: Naphazoline Hydrochloride
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Aluminum Chloride
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 32385307

Group type: EXPERIMENTAL
Intervention: Medium cut-off (MCO) dialyzer (Theranova 400, Baxter)
Number of subjects: 49
Study: 33911186

Group type: EXPERIMENTAL
Intervention: Erythropoiesis stimulating agents (ESAs)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Transfusions
Number of subjects: 80
Study: 32317700

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise (NSE)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Neck-specific exercise with a behavioural approach (NSEB)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Physical activity prescription (PPA)
Number of subjects: 171
Study: 33485309

Group type: EXPERIMENTAL
Intervention: Intervention (personalised cancer risk information and tailored behaviour change advice)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard NHS Health Check
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard chronic disease review
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Chronic disease review plus intervention
Number of subjects: 62
Study: 34889733

Group type: EXPERIMENTAL
Intervention: Topiroxostat 200 mg
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Topiroxostat 80 mg
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Allopurinol 200 mg
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Topiroxostat 120 mg
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Topiroxostat 160 mg
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Topiroxostat 60 mg
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Topiroxostat 40 mg
Number of subjects: 733

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 733
Study: 32503473

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for 12 months, 3 days/week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group maintaining normal lifestyle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention
Number of subjects: 0
Study: 34371933

Group type: EXPERIMENTAL
Intervention: Early dinner (at 18:00)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Late dinner (at 21:00)
Number of subjects: 12
Study: 32631211

Group type: COMPARATOR
Intervention: Minimal Intervention (one-session, information-only, group-delivered)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (two-session, group-delivered)
Number of subjects: 0
Study: 35450451

Group type: EXPERIMENTAL
Intervention: Individualized nursing management program
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine nursing care (control)
Number of subjects: 140
Study: 32776237

Group type: EXPERIMENTAL
Intervention: Counterweight-Plus weight management programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 0
Study: 36256949

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1,000 IU cholecalciferol/d)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 34397820

Group type: EXPERIMENTAL
Intervention: Oolong tea (O‐)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: High concentration simethicone solution (S2‐)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Distilled water (D‐)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Low concentration simethicone solution (S1‐)
Number of subjects: 395
Study: 32941395

Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) Cmin of 4-7 ng/mL
Number of subjects: 904

Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) Cmin of 4-7 ng/mL after propensity score matching
Number of subjects: 904

Group type: COMPARATOR
Intervention: Tacrolimus (TAC) Cmin of 7-10 ng/mL
Number of subjects: 904

Group type: COMPARATOR
Intervention: Tacrolimus (TAC) Cmin of >10 ng/mL
Number of subjects: 904